About VivoPharm
VivoPharm is a company based in Bundoora (Australia) founded in 2003 was acquired by Cancer Genetics in August 2017.. VivoPharm offers products and services including Mammalian Toxicology, Safety Pharmacology, Genetic Toxicology, In Vitro Toxicology, and Analytical Services. VivoPharm operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Yaocheng Health Technology, ReveraGen and Aquila BioMedical, among others.
- Headquarter Bundoora, Australia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vivopharm Global Pty Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Cancer Genetics
(Aug 15, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VivoPharm
VivoPharm offers a comprehensive portfolio of products and services, including Mammalian Toxicology, Safety Pharmacology, Genetic Toxicology, In Vitro Toxicology, and Analytical Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Conducts toxicology studies with various administration routes for pharma.
Evaluates effects of test articles on vital functions in studies.
Provides tiered genetic tests with reliable delivery of results.
Offers cell-based assays for accessible toxicology endpoints.
Delivers LC-MS/MS and HPLC capabilities for sample analysis.
Provides clinical pathology services for contract research.
Funding Insights of VivoPharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in VivoPharm
VivoPharm has secured backing from 1 investor. Prominent investors backing the company include Cancer Genetics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cancer diagnostic solutions are developed for personalized genetic treatments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by VivoPharm
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - VivoPharm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vivopharm Comparisons
Competitors of VivoPharm
VivoPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Yaocheng Health Technology, ReveraGen and Aquila BioMedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| domain | founded_year | HQ Location |
Drug development and preclinical services are provided by Tigermed.
|
|
| domain | founded_year | HQ Location |
Clinical trial services to biopharma sector are provided.
|
|
| domain | founded_year | HQ Location |
Steroids for Duchenne muscular dystrophy treatment are developed.
|
|
| domain | founded_year | HQ Location |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
|
| domain | founded_year | HQ Location |
Contract research on infectious disease models is conducted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about VivoPharm
When was VivoPharm founded?
VivoPharm was founded in 2003.
Where is VivoPharm located?
VivoPharm is headquartered in Bundoora, Australia. It is registered at Bundoora, Victoria, Australia.
What does VivoPharm do?
VivoPharm was founded in 2003 and is based in Bundoora, Australia, operating as a contract research organization in the preclinical sector. Specialized services in oncology and immuno-oncology are delivered, including human xenograft tumor models and syngeneic models. Cell-based assays for in vitro pharmacology and toxicology are conducted, alongside mammalian and genetic toxicity studies, safety pharmacology, clinical pathology, and analytical support for drug development processes.
Who are the top competitors of VivoPharm?
What products or services does VivoPharm offer?
VivoPharm offers Mammalian Toxicology, Safety Pharmacology, Genetic Toxicology, In Vitro Toxicology, and 2 more products and services.
Who are VivoPharm's investors?
VivoPharm has 1 investor. Key investors include Cancer Genetics.